Literature DB >> 11231952

Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.

W Schmidt1, U Wahnschaffe, M Schäfer, T Zippel, M Arvand, A Meyerhans, E O Riecken, R Ullrich.   

Abstract

Highly active antiretroviral therapy (HAART) suppresses the replication of human immunodeficiency virus (HIV) and leads to an increase in circulating CD4 T lymphocytes, but its effects on other immune compartments such as the intestinal mucosa are not well understood. We describe a severely immunodeficient HIV-infected patient with intractable watery diarrhea and weight loss caused by infection with Cryptosporidium parvum in whom we studied virologic and immunologic changes in both peripheral blood and the intestinal mucosa after initiating HAART. Mucosal biopsies were performed by rectoscopy before and at several time points after HAART was begun. Nucleic acids were extracted from rectal biopsy specimens and blood samples, and HIV RNA was measured by reverse-transcription polymerase chain reaction. Lymphocytes were isolated from rectal biopsy specimens after mechanical disaggregation, and circulating and mucosal CD4 T cells were determined by flow cytometry. HAART led to clinical recovery and eradication of cryptosporidiosis. In both blood and mucosa, HIV RNA decreased below the limit of detection and CD4 T cells increased. Mucosal CD4 T cells increased much faster and to much higher levels than circulating CD4 T cells. Our findings show a rapid repopulation of the intestinal mucosa with CD4 T cells after initiation of HAART that can effectively restore mucosal immunity, leading to eradication of opportunistic pathogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231952     DOI: 10.1053/gast.2001.22557

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 2.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

3.  CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice.

Authors:  Daniel S Korbel; Farah M Barakat; James P Di Santo; Vincent McDonald
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

Review 4.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

5.  An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice.

Authors:  Brett A Leav; Masaru Yoshida; Kathleen Rogers; Seth Cohen; Nihal Godiwala; Richard S Blumberg; Honorine Ward
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Nuclear delivery of parasite Cdg2_FLc_0220 RNA transcript to epithelial cells during Cryptosporidium parvum infection modulates host gene transcription.

Authors:  Guang-Hui Zhao; Ai-Yu Gong; Yang Wang; Xin-Tian Zhang; Min Li; Nicholas W Mathy; Xian-Ming Chen
Journal:  Vet Parasitol       Date:  2017-12-20       Impact factor: 2.738

7.  High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity.

Authors:  Heuy-Ching Wang; Sara M Dann; Pablo C Okhuysen; Dorothy E Lewis; Cynthia L Chappell; Douglas G Adler; A Clinton White
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

Review 8.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

9.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

10.  Trans-suppression of defense DEFB1 gene in intestinal epithelial cells following Cryptosporidium parvum infection is associated with host delivery of parasite Cdg7_FLc_1000 RNA.

Authors:  Zhenping Ming; Ai-Yu Gong; Yang Wang; Xin-Tian Zhang; Min Li; Courtney E Dolata; Xian-Ming Chen
Journal:  Parasitol Res       Date:  2018-01-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.